Veggie Rx: A pilot, 3-arm randomized controlled trial of a fruit and vegetable prescription program for patients with type two diabetes
Veggie Rx:针对二型糖尿病患者的水果和蔬菜处方计划的试点、三组随机对照试验
基本信息
- 批准号:10735542
- 负责人:
- 金额:$ 33.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultCaloriesCaringCarotenoidsClinicClinicalClinical TrialsCommunitiesConsumptionControl GroupsDataDiabetes MellitusDietDietary intakeDiseaseEducationEnrollmentEthnic OriginEvaluationFacultyFatty acid glycerol estersFoodFutureGlycosylated hemoglobin AHealthy EatingHispanicHourHouseholdIncentivesIntakeInterventionKnowledgeLow Income PopulationLow incomeMeasuresMedicaidMedicalMethodologyMindMissionNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusNot Hispanic or LatinoNutrientOutcomeParticipantPathway interactionsPatientsPharmaceutical PreparationsPlasmaProcessProctor frameworkProgram AppropriatenessRaceRandomized, Controlled TrialsRecommendationResearchSurveysTaxonomyTestingWorkagedarmblood glucose regulationcare providersclinical carecostdesigndiabetes self-managementdietary guidelinesfood insecurityfood securityfruits and vegetablesglycemic controlgroup interventionhigh riskhispanic communityimplementation outcomesimplementation scienceimprovedindexinginnovationnutritionprimary care clinicprogramsresponsesexsociodemographic factorssociodemographicssugartreatment as usualtreatment planningtrial designuptakeusual care armvoucher
项目摘要
Abstract. Consuming a nutrient-dense diet, rich in fruits and vegetables (F&Vs) is at the cornerstone of type 2
diabetes (T2DM) treatment. Yet, among Hispanic adults, only 16% meet the recommended minimum F&V
intake recommendations and they have higher rates of T2DM than non-Hispanic whites (16.6% versus 13.3%,
respectively). F&V Prescription (F&V Rx) programs are embedded in clinical settings, target medically high-risk
patients such as those with T2DM, and provide them with vouchers to purchase F&V at local retailers.
Preliminary F&V Rx studies in patients with T2DM have found F&V intake increases of 0.2-1.6 servings per
day and hemoglobin A1c (A1c) reductions from 0.35-0.71% [3.8 -7.8 mmol/mol]. However, none of these
studies included diabetes self-management education and support (DSME/S) which can lead to A1c decreases
from 0.24% to 1.0% [2.6-10.9 mmol/mol]. Our team conducted a pilot F&V Rx study where we incentivized
DSME/S attendance by providing a F&V Rx at each session. Although DSME/S uptake is typically very low
after referral (around 5-7%), our program had a 73% first session attendance rate. Further, at 7 months post-
program, we found a clinically- and statistically-significant reduction in A1c of 1.3% [14.2 mmol/mol] (p=.001).
Although the receipt of the F&V Rx vouchers was contingent upon DSME/S attendance in our study, other
T2DM-focused F&V Rx studies did not have DSME/S attendance requirements and they also saw A1c
reductions. Thus, understanding the effect of a F&V Rx on DSME/S uptake and retention with and without
attendance requirements is a key design issue that must be evaluated. This proposal is in response to PAS 20-
160 for short-term, pilot randomized controlled trials (RCTs) to acquire preliminary data regarding trial design.
We propose a 3-Arm, 16-week, pilot RCT (n=120) for low-income adults (aged 18+) with T2DM (A1c >7% [53
mmol/mol]). The control group (n=40) will receive usual care (UC). The two intervention groups (n=40 each)
will receive UC plus a F&V Rx that is either independent of DSME/S attendance (F&V Rx alone) or dependent
on DSME/S attendance (F&V Rx + DSME/S). First, we will systematically explore the impact of a F&V Rx on
uptake and retention in DSME/S. Next, we will explore changes in A1c, and diet-related outcomes. Finally, with
implementation in mind, we will use Proctor’s implementation taxonomy, and the cultural adaptation framework
from Castro et al., to assess program appropriateness, acceptability, and sustainability with both participants
and clinical care providers. Our study team and our Community Advisory Board (CAB) have the research,
clinical expertise, and established retail network necessary to conduct a F&V Rx trial in a low-income, Hispanic
community. The findings of this trial will inform the design of a future, fully powered RCT and address gaps in
our knowledge related to how F&V Rx programs impact T2DM-related outcomes. If effective, F&V Rx
programs have the potential to improve diabetes self-management and reduce the clinical burden of poor
glycemic control, particularly in low-income, Hispanic communities.
摘要。食用富含水果和蔬菜的营养丰富的饮食是2型糖尿病的基础
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Veldheer其他文献
Susan Veldheer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




